Do you know what’s in your drinking water?
// <!-- -->// // // // <!-- -->// // // // <!-- -->//...
Bollywood Briefs: Aamir’s weight loss leaves B-Town curious
Aamir's weight loss leaves B-Town curious
Mumbai--Aamir Khan, who revealed his lean look last month, took many in the film fraternity by surprise, especially since...
Indian defence exports surged in 2015
By Anjali Ojha
New Delhi-- As India focuses on enhancing domestic production of military hardware, a surge in its export was recorded in nine months...
Exercise may delay brain aging by 10 years
New York-- Want to keep a sharp memory in old age? A study has found that moderate to intense regular exercise in old age...
MIT: Lost memories can indeed be retrieved
CAMBRIDGE, MA--In the early stages of Alzheimer's disease, patients are often unable to remember recent experiences. However, a significant research suggests that those memories...
Hong Kong aims to attract Indian entertainment industry to FILMART
By Venkatachari Jagannathan
Hong Kong-- The Hong Kong Trade Development Council (HKTDC) will focus on attracting more Indian film production houses and others involved in...
Indians wondering how with $1.5 billion debt business tycoon Vijay Mallya left the country
New Delhi-- Even as the Indian government on Thursday assured that "every possible action will be taken" against beleaguered liquor baron Vijay Mallya, the...
U.S. Attorney Ortiz Launches Independent Investigation of Alleged Civil Rights Violations at Boston Latin...
BOSTON – United States Attorney Carmen M. Ortiz announced that the Civil Rights Unit of the U.S. Attorney’s Office for the District of Massachusetts...
IIT AGNE to Host Free Symposium: Boundary-less Education: Connect, and Collaborate to Transform Education
CAMBRIDGE, MA— IIT AGNE and iit2016-Leadership Conference are organizing a symposium on “Boundary-less Education: Connect, and Collaborate to Transform Education” on March 5 in...
India’s Cipla acquires two US drug firms for $550 million
Mumbai--Drug major Cipla has acquired two US-based firms -- InvaGen Pharmaceuticals and Exelan Pharmaceuticals -- for $550 million, the company said in a regulatory...
